Form 4 for RCKT ROCKET PHARMACEUTICALS, INC.
Accepted 2024-08-20 00:00:00 ET · period of report 2024-08-16 · accession 0001140361-24-037932 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-08-20 | 2024-08-16 | RCKT | Shah Gaurav | CEO, Dir | S - Sale | $18.50 | -9,650 | 718.4K | -1% | -$178.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-08-16 | S | D | 9,650 | $18.50 | 718,419 | D | — | — |